Transcriptional Fingerprinting meets Drug Discovery


Transcriptional Fingerprinting meets Drug Discovery


Transcriptional Fingerprinting meets Drug Discovery

Mission


 

QUANTRO will combine and exploit innovative technologies in the areas of functional-genetics and transcriptomics to generate an unprecedented cancer drug discovery pipeline transforming the precision and scope of cell-based compound screens.

Read more about the Company & Our Science.

NEWS: April 04, 2023

QUANTRO Therapeutics appoints Industry Expert Dr. Michael Bauer as Chief Executive Officer

EN | DE
Contact

Job Offers

QUANTRO Therapeutics GmbH
Dr. Bohr-Gasse 7
A-1030 Vienna, Austria

+43 122 66001-20

© 2023 QUANTRO Therapeutics GmbH